gland pharma glp-1 manufacturing capacity India's pharmaceutical industry is witnessing another massive strategic move 💊📈 Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a ₹1,369 crore deal, signaling stronger expansion, integrated Is This The Pharma Supercycle

Bian J, Liebert A, Bicknell B, Chen X-M, Huang C, Pollock CA (2022) Faecal microbiota transplantation and chronic kidney disease

d , Immunoblots of indicated proteins in HEK-293T cells expressing a vector control or GshF cDNA

Con: No GLP-1 friendly standard When it comes to label claims, the lack of standardization of GLP-1 friendly is the ultimate con for brands looking to enter this space

The True Meaning of Patient Autonomy Patient autonomy is the right to make informed decisions about your health

My case is fully defensible My patient is demanding an unwarranted refund How do I safely terminate doctor-patient relationship

Atiya et al